摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenyl monomethyl glutarate

中文名称
——
中文别名
——
英文名称
2-phenyl monomethyl glutarate
英文别名
5-Methoxy-5-oxo-4-phenylpentanoic acid
2-phenyl monomethyl glutarate化学式
CAS
——
化学式
C12H14O4
mdl
——
分子量
222.241
InChiKey
YFPCPKOUODSSTM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-phenyl monomethyl glutarate二丁基二氯化锡三乙胺 作用下, 以85%的产率得到dibutyltin bis(2-phenylmonomethylglutarate)
    参考文献:
    名称:
    Synthesis, spectral characterization, antibacterial and antitumor studies of some diorganotin(IV) complexes derived from 2-phenylmonomethylglutarate
    摘要:
    A novel series of diorganotin(IV) complexes of the type R2SnL2 (R = Me, Et, Bu, Ph Bz and L = 2-phenylmonomethylglutarate) has been reported herein. The synthesized compounds has been characterized by elemental analysis and their solid state configuration has been determined by various spectroscopic (IR, H-1, C-13, Sn-119 NMR, Sn-119m Mossbauer) techniques. The results obtained are in full agreement with the proposed 2:1 stoichiometry. The title complexes have been screened against various Gram positive and Gram negative bacteria and human cell line KB, the results obtained showed that the diphenyltin(IV) complex exhibited excellent activity against all types of bacteria, while diethyltin(IV) complex was found to have promising antitumor activity. (C) 2014 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ica.2014.08.006
  • 作为产物:
    描述:
    甲醇2-苯基戊二酸酐 反应 10.0h, 以75%的产率得到2-phenyl monomethyl glutarate
    参考文献:
    名称:
    Synthesis, spectral characterization, antibacterial and antitumor studies of some diorganotin(IV) complexes derived from 2-phenylmonomethylglutarate
    摘要:
    A novel series of diorganotin(IV) complexes of the type R2SnL2 (R = Me, Et, Bu, Ph Bz and L = 2-phenylmonomethylglutarate) has been reported herein. The synthesized compounds has been characterized by elemental analysis and their solid state configuration has been determined by various spectroscopic (IR, H-1, C-13, Sn-119 NMR, Sn-119m Mossbauer) techniques. The results obtained are in full agreement with the proposed 2:1 stoichiometry. The title complexes have been screened against various Gram positive and Gram negative bacteria and human cell line KB, the results obtained showed that the diphenyltin(IV) complex exhibited excellent activity against all types of bacteria, while diethyltin(IV) complex was found to have promising antitumor activity. (C) 2014 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ica.2014.08.006
点击查看最新优质反应信息

文献信息

  • US6294577B1
    申请人:——
    公开号:US6294577B1
    公开(公告)日:2001-09-25
  • Synthesis, spectral characterization, antibacterial and antitumor studies of some diorganotin(IV) complexes derived from 2-phenylmonomethylglutarate
    作者:Wajid Rehman、Amin Badshah、Fazal Rahim、Musa Kaleem Baloch、Hameed Ullah、Obaid-Ur-Rahman Abid、Mohsan Nawaz、Isfahan Tauseef
    DOI:10.1016/j.ica.2014.08.006
    日期:2014.11
    A novel series of diorganotin(IV) complexes of the type R2SnL2 (R = Me, Et, Bu, Ph Bz and L = 2-phenylmonomethylglutarate) has been reported herein. The synthesized compounds has been characterized by elemental analysis and their solid state configuration has been determined by various spectroscopic (IR, H-1, C-13, Sn-119 NMR, Sn-119m Mossbauer) techniques. The results obtained are in full agreement with the proposed 2:1 stoichiometry. The title complexes have been screened against various Gram positive and Gram negative bacteria and human cell line KB, the results obtained showed that the diphenyltin(IV) complex exhibited excellent activity against all types of bacteria, while diethyltin(IV) complex was found to have promising antitumor activity. (C) 2014 Elsevier B.V. All rights reserved.
查看更多